Hormone replacement therapy and cardiovascular disease: does route of administration and formulation matter?

被引:2
作者
Foster, W [1 ]
Lip, GYH [1 ]
机构
[1] Univ Birmingham, City Hosp, Dept Med, Haemostasis Thrombosis & Vasc Biol Unit, Birmingham, W Midlands, England
关键词
hormone replacement therapy; oestrogen; coronary heart disease; vascular function; atherosclerosis;
D O I
10.1111/j.1365-2141.2004.04847.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:836 / 840
页数:5
相关论文
共 37 条
[1]   Evidence from randomised trials on the long-term effects of hormone replacement therapy [J].
Beral, V ;
Banks, E ;
Reeves, G .
LANCET, 2002, 360 (9337) :942-944
[2]   Endothelin-1 and nitric oxide levels are related to cardiovascular risk factors but are not modified by estradiol replacement in healthy postmenopausal women. A cross-sectional and a randomized cross-over study [J].
Cagnacci, A ;
Tarquini, R ;
Perfetto, F ;
Arangino, S ;
Zanni, AL ;
Cagnacci, P ;
Facchinetti, F ;
Volpe, A .
MATURITAS, 2003, 44 (02) :117-124
[3]  
CAINE YG, 1992, THROMB HAEMOSTASIS, V68, P392
[4]   Assessment of endothelial damage and dysfunction: observations in relation to heart failure [J].
Chong, AY ;
Blann, AD ;
Lip, GYH .
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2003, 96 (04) :253-267
[5]   Effect of postmenopausal hormones on inflammation-sensitive proteins - The Postmenopausal Estrogen/Progestin Interventions (PEPI) Study [J].
Cushman, M ;
Legault, C ;
Barrett-Connor, E ;
Stefanick, ML ;
Kessler, C ;
Judd, HL ;
Sakkinen, PA ;
Tracy, RP .
CIRCULATION, 1999, 100 (07) :717-722
[6]   Risk of venous thromboembolism in users of hormone replacement therapy [J].
Daly, E ;
Vessey, MP ;
Hawkins, MN ;
Carson, JL ;
Gough, P ;
Marsh, S .
LANCET, 1996, 348 (9033) :977-980
[7]   Cardiovascular risk in women: the cardiologist's perspective [J].
Edmunds, E ;
Lip, GYH .
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2000, 93 (03) :135-145
[8]   Cardiovascular disease outcomes during 6.8 years of hormone therapy - Heart and Estrogen/progestin Replacement Study follow-up (HERS II) [J].
Grady, D ;
Herrington, D ;
Bittner, V ;
Blumenthal, R ;
Davidson, M ;
Hlatky, M ;
Hsia, J ;
Hulley, S ;
Herd, A ;
Khan, S ;
Newby, LK ;
Waters, D ;
Vittinghoff, E ;
Wenger, N .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (01) :49-57
[9]   HORMONE-THERAPY TO PREVENT DISEASE AND PROLONG LIFE IN POSTMENOPAUSAL WOMEN [J].
GRADY, D ;
RUBIN, SM ;
PETITTI, DB ;
FOX, CS ;
BLACK, D ;
ETTINGER, B ;
ERNSTER, VL ;
CUMMINGS, SR .
ANNALS OF INTERNAL MEDICINE, 1992, 117 (12) :1016-1037
[10]   Postmenopausal hormone replacement therapy and the primary prevention of cardiovascular disease [J].
Humphrey, LL ;
Chan, BKS ;
Sox, HC .
ANNALS OF INTERNAL MEDICINE, 2002, 137 (04) :273-284